**DMS Imaging** is a renowned player in the medical diagnostic technology sector, specializing in high-tech solutions. With a history dating back to **1979**, the company has established itself as a key player in the industry, with a strong focus on the development, design, and manufacturing of medical imaging systems, with a primary production center located in the South of France (Gallargues-le-Montueux). The company boasts over 40 years of experience and has built an extensive network of **140 distributors** globally. It has also formed crucial partnerships with major OEMs, such as **Fujifilm**, **Canon Medical Systems Europe**, and **Carestream**, which enhances the international dimension of its products. DMS Imaging's offerings span a wide range of imaging systems, including its acclaimed R/F Solution, the **Platinum Neo**, and bone densitometry solutions, **Stratos** and **Stratos dR**, positioning the company as a leader in the R/F and bone densitometry markets. DMS Imaging's software platform, **ADAM**, embodies its commitment to bringing intelligence to imaging, with unique functions and improved workflow. The company's presence in major French purchasing groups (**UGAP**, **Resah**, and **UniHA**) and its membership in the French Healthcare Association further reinforce its reputation. Notably, DMS Imaging clinched the prestigious **JFR Innovation Award** in 2021 for its groundbreaking R/F solution, the **Platinum Neo**. With its strong track record, innovative products, and established partnerships, DMS Imaging presents an attractive investment opportunity for venture capital firms seeking to tap into the evolving landscape of high-tech medical imaging solutions.
There is no investment information